PortfoliosStock ScreensStocksStockXcel

Tenaya Therapeutics Inc. Common Stock

TNYA | US

0.69

USD

-0.05

-6.76%

TNYA | US

About Tenaya Therapeutics Inc. Common Stock

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

10/04/2026

Close

0.69

Open

0.74

High

0.74

Low

0.68

Tenaya Therapeutics Inc. a biotechnology company discovers develops and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration gene therapy and precision medicine platforms. The company is developing TN-201 a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy; TN-301 a small molecule for heart failure with preserved ejection fraction; and TN-401 a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy. It also develops an adeno-associated virus-based gene therapy designed to deliver the dwarf open reading frame gene in the heart for dilated cardiomyopathy; and reprogramming program for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco California.

View Less

TNYA | US

Risk
76.6
Sharpe
0.54
Luna's Score
45/100
Recommendation
Sell

Luna says (TNYA | US)

What's Working

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

What's not Working

Negative Momentum (Declining Price)

Weakness based on declining price with high volume

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

101.2%

1 month

76.6%

3 months

124.9%

6 months

121.6%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

1.27

Debt to equity

0.12

Debt to assets

0.10

Ent. to EBITDA

-0.67

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-118.31M

MarketCap

70.48M

MarketCap(USD)

70.48M

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

-

Ret. on equity

-74.54

Short ratio

12.39

Short perc.

9.23

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

0.16

Range1M

0.34

Range3M

0.50

Volumes: Market Activity

Rel. volume

1.26

Price X volume

2.84M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
CRDFCRDFBiotechnology1.5873.55M-5.39%n/a3.52%
Fortress Biotech IncFBIOPBiotechnology13.6873.43M-0.73%n/a494.61%
MediciNova IncMNOVBiotechnology1.4973.08M4.93%n/a0.86%
Oncolytics Biotech Inc. (USA)ONCYBiotechnology0.9371.48M-10.58%n/a0.00%
XBiotech IncXBITBiotechnology2.3370.98M0.00%n/a5.08%
BeyondSpring IncBYSIBiotechnology1.7470.12M-1.69%n/a-14.90%
CNS PHARMACEUTICALS INCCNSPBiotechnology2.1870.08M2.35%n/a-2.87%
PMV Pharmaceuticals IncPMVPBiotechnology1.3268.01M-0.75%n/a6.06%
Biomea Fusion Inc. Common StockBMEABiotechnology1.8767.71M1.08%n/a9.95%
Fortress Biotech IncFBIOBiotechnology2.3564.77M-2.08%n/a494.61%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Saga Communications IncSGABroadcasting - Radio11.7873.76M1.38%14.487.10%
ILAGILAGBuilding Products & Equipment3.5564.11M0.00%n/a5.48%
Beasley Broadcast Group IncBBGIBroadcasting - Radio11.7617.91M6.72%n/a204.46%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment1.0815.78M-6.90%0.0316.03%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.60111.61M-7.68%n/a58.43%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.343.42M3.08%n/a17.32%
Twin Vee PowerCats Co. Common StockVEEERecreational Vehicles0.25362.41M-15.10%n/a19.98%
Vision Marine Technologies IncVMARRecreational Vehicles2.091.15M7.18%n/a0.00%
Micromobility.com Inc.MCOMRecreational Vehicles0.006553.29Kn/a-37.05%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-0.67-Cheaper
Ent. to Revenue---
PE Ratio-41.03-
Price to Book1.2715.55Cheaper
Dividend Yield---
Std. Deviation (3M)124.90-Riskier
Debt to Equity0.12-1.23Expensive
Debt to Assets0.100.25Cheaper
Market Cap70.48M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007